Condition
Nausea and Vomiting Caused by Trastuzumab Deruxtecan clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Nausea and Vomiting Caused by Trastuzumab Deruxtecan clinical trials that are recruiting, in China. By phase: Phase 3 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Auricular point stimulation with dexamethasone versus standard antiemetics for nausea from trastuzumab deruxtecan
This trial tests whether adding ear acupuncture-style stimulation to dexamethasone can prevent and reduce nausea and vomiting caused by trastuzumab deruxtecan in breast cancer patients, compared with the usual antiemetic regimen.
-
Ear acupressure plus dexamethasone to prevent nausea and vomiting from trastuzumab deruxtecan
This trial will try ear acupressure combined with a standard dose of dexamethasone to prevent or reduce nausea and vomiting in breast cancer patients receiving trastuzumab deruxtecan.
Related topics
Quick answers
How many Nausea and Vomiting Caused by Trastuzumab Deruxtecan clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.